These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 2497130

  • 1. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
    Permezel JM, Lenton EA, Roberts I, Cooke ID.
    J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
    [Abstract] [Full Text] [Related]

  • 2. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [Abstract] [Full Text] [Related]

  • 3. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [Abstract] [Full Text] [Related]

  • 4. Gonadotropin, estrogen and progesterone response to long term gonadotropin-releasing hormone infusion at various stages of the menstrual cycle.
    Jewelewicz R, Dyrenfurth I, Ferin M, Bogumil J, Vande Wiele RL.
    J Clin Endocrinol Metab; 1977 Oct; 45(4):662-7. PubMed ID: 334788
    [Abstract] [Full Text] [Related]

  • 5. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 6. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G, George M, Lestrat N, Reinberg A, Baulieu EE.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [Abstract] [Full Text] [Related]

  • 7. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM, Thompson IE, Taymor ML.
    Acta Endocrinol (Copenh); 1975 Aug; 79(4):625-34. PubMed ID: 1098349
    [Abstract] [Full Text] [Related]

  • 8. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R, Messinis LE, Fowler P, Groome NP, Knight PG, Templeton AA.
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [Abstract] [Full Text] [Related]

  • 9. Experimental studies on the positive feedback effect of progesterone, 17 alpha-hydroxyprogesterone and 20 alpha-dihydroprogesterone on the pituitary release of LH and FSH in the human female. The estrogen priming of the progesterone feedback on pituitary gonadotropins in the eugonadal woman.
    Leyendecker G, Wildt L, Gips H, Nocke W, Plotz EJ.
    Arch Gynakol; 1976 Dec; 221(1):29-45. PubMed ID: 989265
    [Abstract] [Full Text] [Related]

  • 10. Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist?
    Collins RL, Hodgen GD.
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1270-6. PubMed ID: 3097053
    [Abstract] [Full Text] [Related]

  • 11. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation.
    Batista MC, Cartledge TP, Zellmer AW, Nieman LK, Merriam GR, Loriaux DL.
    J Clin Endocrinol Metab; 1992 Mar; 74(3):565-70. PubMed ID: 1740491
    [Abstract] [Full Text] [Related]

  • 12. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ, Kettel LM, Rivier J, Burger HG, Baulieu E, Yen SS.
    Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
    [Abstract] [Full Text] [Related]

  • 13. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
    Sheehan KL, Casper RF, Yen SS.
    Am J Obstet Gynecol; 1979 Nov 15; 135(6):759-63. PubMed ID: 386801
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T, Heikinheimo O, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1988 Jun 15; 49(6):961-3. PubMed ID: 3371492
    [Abstract] [Full Text] [Related]

  • 15. Tonic support of luteinizing hormone secretion by adrenal progesterone in the ovariectomized monkey replaced with midfollicular phase levels of estradiol.
    Xiao E, Xia-Zhang L, Shanen D, Ferin M.
    J Clin Endocrinol Metab; 1997 Jul 15; 82(7):2233-8. PubMed ID: 9215299
    [Abstract] [Full Text] [Related]

  • 16. Variable effects of RU 486 on endometrial maintenance in the luteal phase extended by exogenous hCG.
    Croxatto HB, Salvatierra AM, Croxatto HD, Spitz IM.
    Clin Endocrinol (Oxf); 1989 Jul 15; 31(1):15-23. PubMed ID: 2598478
    [Abstract] [Full Text] [Related]

  • 17. Hypersensitivity of the human gonadotrophs to the repeated administration of small doses of LH-RH.
    Faure N, Olivier GC.
    Horm Res; 1978 Jul 15; 9(1):12-21. PubMed ID: 338460
    [Abstract] [Full Text] [Related]

  • 18. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
    Lasley BL, Wang CF, Yen SS.
    J Clin Endocrinol Metab; 1975 Nov 15; 41(5):820-6. PubMed ID: 1102551
    [Abstract] [Full Text] [Related]

  • 19. Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase.
    Shoupe D, Mishell DR, Page MA, Madkour H, Spitz IM, Lobo RA.
    Am J Obstet Gynecol; 1987 Dec 15; 157(6):1421-6. PubMed ID: 2827482
    [Abstract] [Full Text] [Related]

  • 20. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML, Bygdeman M, Cekan S, Xing S, Masironi B, Johannisson E.
    Hum Reprod; 1990 May 15; 5(4):402-8. PubMed ID: 2113927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.